TipHub

108.25

+2.48 +2.34%

29 Jul 2026

NSE Listed · Pharmaceuticals

Themis Medicare Ltd. (THEMISMED)

Volume: 16,250Avg Vol 1W: 33,701Avg Vol 1M: 1,79,73652W Range:64.95148
Market Cap₹997 Cr
Current Price₹108.25
Previous Close₹105.77
High / Low (52w)₹148 / ₹64.95
Volume16,250
Avg Vol (1W)33,701
Avg Vol (1M)1,79,736
Stock P/E601.39
Book Value₹39.7
Dividend Yield47%
ROE41.57%
ROA19.07%
Revenue (TTM)
Revenue Growth6.22%
Profit Margin33.31%
Total Debt₹19 Cr
Shares Outstanding9 Cr
Face Value₹1
EPS (TTM)₹0.18
P/B2.73
Debt / Equity0.25
50 DMA₹109.1
200 DMA₹100.65
Day change+2.34%
Price Chart
108.25 4.12% · 1Y
195661.5Cr
2025-07-29
2026-07-29

20-day avg volume: 1.8L shares

Pros
  • Healthy return on equity of 41.6%.
  • Pays a dividend yield of 47.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 15% YoY.
  • Stock trades at a high P/E of 601.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹123 Cr₹117 Cr₹94 Cr₹72 Cr₹98 Cr₹78 Cr₹90 Cr₹77 Cr
EBITDA₹28 Cr₹16 Cr₹7 Cr₹-7 Cr₹-11 Cr₹-2 Cr₹8 Cr₹5 Cr
Net Profit₹25 Cr₹14 Cr₹1 Cr₹-10 Cr₹-14 Cr₹-4 Cr₹10 Cr₹9 Cr
EPS
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹117 Cr₹94 Cr₹72 Cr₹410 Cr₹98 Cr₹78 Cr₹90 Cr₹77 Cr
EBITDA₹16 Cr₹7 Cr₹-7 Cr₹44 Cr₹-11 Cr₹-2 Cr₹8 Cr₹5 Cr
Net Profit₹10 Cr₹3 Cr₹-8 Cr₹30 Cr₹-15 Cr₹-5 Cr₹5 Cr₹2 Cr
EPS3.24
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹305 Cr₹314 Cr₹350 Cr₹371 Cr₹428 Cr₹514 Cr₹566 Cr₹588 Cr
Total Liabilities₹136 Cr₹156 Cr₹167 Cr₹153 Cr₹140 Cr₹175 Cr₹189 Cr₹185 Cr
Equity₹169 Cr₹158 Cr₹183 Cr₹219 Cr₹287 Cr₹339 Cr₹378 Cr₹403 Cr
Total Debt
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹7 Cr₹11 Cr₹1 Cr₹57 Cr₹52 Cr₹32 Cr₹31 Cr₹45 Cr
Investing₹0 Cr₹-4 Cr₹-5 Cr₹-16 Cr₹-16 Cr₹-24 Cr₹-16 Cr₹-12 Cr
Financing₹-9 Cr₹-10 Cr₹7 Cr₹-26 Cr₹-18 Cr₹0 Cr₹-9 Cr₹-26 Cr
Free Cash Flow₹7 Cr₹11 Cr₹1 Cr₹57 Cr₹52 Cr₹32 Cr₹31 Cr₹45 Cr
Shareholding
Promoter 67.11% Institutions 0.02% Public 32.87%
Efficiency & Working Capital
ROCE2.7%
Interest Coverage5
Dividend Payout
Debtor Days159 d
Inventory Days76 d
Payable Days46 d
Cash Conversion Cycle189 d
Working Capital Days235 d
Shareholding Details

As of 2026-06-30

Promoter67.1%
FII0%
DII0%
Institutions0%
Public32.9%
Promoter Pledge43.4%
No. of Shareholders21,267
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters67.2%67.2%67.1%67.1%67.1%67.1%67.1%67.1%67.1%67.1%67.1%67.1%
FIIs0.1%0%0%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public32.8%32.8%32.8%32.8%32.7%32.7%32.7%32.7%32.8%32.8%32.8%32.9%
Promoter Pledge23.5%2.4%2.4%2.4%2.4%2.4%2.4%2.4%2.4%2.4%2.4%43.4%
No. of Shareholders6,97011,24411,29511,32214,27017,77317,88919,33522,49022,57621,81821,267
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Dinesh Shantilal Patel, Jayshree Dinesh Patel, Sachin Dinesh Patel (trustees Of Vividhmargi Trust)Shareholding of Promoter and Promoter Group27.5%2.53 Cr
Vividhmargi Investments Private LimitedShareholding of Promoter and Promoter Group26.5%2.44 Cr
Gedeon Richter Investment Management Ltd.Shareholding of Promoter and Promoter Group9.6%88,43,080
Anuj Anantrai ShethPublic Shareholding3.8%35,00,000
Zafar AhmadullahPublic Shareholding2.1%19,45,964
Za Capital Services India Private LtdPublic Shareholding1.5%14,11,893
Anay Rupen ChoksiShareholding of Promoter and Promoter Group1.3%11,76,890
Nysha Rupen ChoksiShareholding of Promoter and Promoter Group1.3%11,76,890
Shantilal Dahyabhai Patel HufShareholding of Promoter and Promoter Group0.6%5,58,000
Dinesh Shantilal PatelShareholding of Promoter and Promoter Group0.3%3,00,020
Rupen Ashwin ChoksiShareholding of Promoter and Promoter Group0%2,000
Jayshree D PatelShareholding of Promoter and Promoter Group0%10
Reena S PatelShareholding of Promoter and Promoter Group0%10
Sachin Dinesh PatelShareholding of Promoter and Promoter Group0%10
Vividh Distributors Pvt LtdShareholding of Promoter and Promoter Group0%0
Themis Distributors Private LimitedShareholding of Promoter and Promoter Group0%0
Dinesh Patel HufShareholding of Promoter and Promoter Group0%0
Oss Software Solutions Labs Private LimitedShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Dinesh Shantilal Patel, Jayshree Dinesh Patel, Sachin Dinesh Patel (trustees Of Vividhmargi Trust)2.53 Cr100%2026-06-30
Vividhmargi Investments Private Limited15,00,0006.1%2026-06-30
Board of Directors
NameDesignationYear
Dinesh S PatelChairman & Exec. Director2025
Sachin D PatelED / MD / CEO / Promoter2025
Reena S PatelNon-Exec & Non-Independent Dir2025
Rajneesh AnandNon-Exec & Non-Independent Dir2025
Adam DemeterNon-Exec & Non-Independent Dir2025
Bhaskar Vemban IyerIndependent Non Exe. Director2025
Shishir DalalIndependent Non Exe. Director2025
Nikunt RavalIndependent Non Exe. Director2025
Neha ThakoreIndependent Director2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr
Segments — Geography
RegionRevenueShare
India₹328 Cr81.9%
Outside India₹72 Cr18.1%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹11099
Corporate Actions
TypeDateValueRemark
dividend2025-09-04₹0.5 (50%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20250204215221
202500045661
20250200159160
Insider / Designated-Person Trades

4 recent disclosure(s)

Prakash NaringrekarDisposal · 100
Prakash NaringrekarDisposal · 200
Prakash NaringrekarDisposal · 467
Prakash NaringrekarDisposal · 33
Substantial Acquisitions (SAST)

1 disclosure(s)

Market24/09/2024 - 25/09/2024 · 3,79,770
Company Information
Incorporated1969
ChairmanDinesh S Patel
AuditorKrishaan & Co
Investor Email[email protected]; cfoassist@th
🌐 www.themismedicare.com

📍 Plot No 69 A GIDC Indl Estate, Vapi, Valsad, Gujarat, 396195

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search